Noxopharm Raises $1.5 Million, Seeks Up to $1 Million More for Drug Development
NOX: $0.048 -2.04% · MC: $12M
Noxopharm has secured commitments for a $1.5 million share placement and plans a non-underwritten share purchase plan targeting up to $1 million, while arranging early conversion of $3.78 million in shareholder notes on the placement terms. The funds are intended to support its SOF-SKN lupus study and other research, with the placement price set at a discount to recent trading prices; the share plan and some associated securities remain subject to their stated terms and approvals.

Comments